Stefano Togni, chief commercial officer at Indena, discussed how the industry is at the intersection of botanical science, delivery formats, and pharmaceutical rigor applied to nutraceuticals. He underscored that the biology of ingredients needs to drive format choice, not always trends. Also, brands want to go to market faster while maintaining scientific depth, a paradox that Togni said Indena is equipped to solve. Togni also discussed the potential of nutrition to support GLP-1 users in managing metabolic health throughout life.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement






















